Novartis announced new MONALEESA pooled analysis results showing that 25% of HR+/HER2- metastatic breast cancer patients treated first-line with Kisqali plus endocrine therapy remained ...
RWE announced that Katja Wünschel, CEO of its renewables business in Europe and Australia, will leave the company on 31 March 2026 to join Vonovia as Chief Development Officer. Sopna Sury, currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback